Snowball logo
logo
3010

Xinxiang Tuoxin Pharmaceutical Co.Ltd.

301089 SHE
¥25.95¥0.00  (0%)
Estimate
EPS
-0.6
Beta
-0.598
Growth
Revenue, YoY
-3.58%
Net income, YoY
39.01%
FCF, YoY
74.99%
About the company
Ticker
301089
ISIN
CNE100004YC3
Country
China
Sector (GICS)
Healthcare
Tuoxin Pharmaceutical Group Co.,Ltd. engages in the research and development, production and sales of nucleoside (acid) APIs and pharmaceutical intermediates in China. It offers nucleoside (acid) products, such as pyrimidine series, purine series, and nucleotide series; nucleoside series, including citicoline sodium, ribavirin, inosine, acyclovir, cytosine, 5-fluorocytosine, cytidine, uridine; and other APIs and pharmaceutical intermediates covering antiviral, anti-tumor, and nervous system. The company was founded in 2001 and is based in Xinxiang, China.

Frequently asked questions

What sector does Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) operate in?

Xinxiang Tuoxin Pharmaceutical Co.Ltd. belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) current stock price?

As of the latest data, Xinxiang Tuoxin Pharmaceutical Co.Ltd. stock price is CN¥25.95, with a previous close of CN¥25.95.

What is Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) current market capitalization?

Xinxiang Tuoxin Pharmaceutical Co.Ltd. market cap is approximately 3.28 billion.

What is Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) Earnings Per Share (EPS)?

The trailing EPS is -CN¥0.60.

Does Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) pay dividends?

No. Xinxiang Tuoxin Pharmaceutical Co.Ltd. does not pay a dividend.

What is Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) beta (volatility) score?

Xinxiang Tuoxin Pharmaceutical Co.Ltd. has a beta of -0.598, indicating lower volatility than the overall market.